Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.

[1]  P. Mandelstam,et al.  A study of the mechanism of intestinal absorption of benzo(a)pyrene. , 1971, Biochimica et biophysica acta.

[2]  Eder Ha.  The effect of diet on the transport of probucol in monkeys. , 1982 .

[3]  M. Lemaire,et al.  Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats. , 1983, Biopharmaceutics & drug disposition.

[4]  K J Palin,et al.  The effect of different oils on the absorption of probucol in the rat , 1984, The Journal of pharmacy and pharmacology.

[5]  V. Stella,et al.  Lymphatic appearance of DDT in thoracic or mesenteric lymph duct cannulated rats , 1985 .

[6]  V. Stella,et al.  Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules , 1986 .

[7]  J. Kvetina,et al.  The pharmacokinetics of intraduodenally administered diazepam in rats as influenced by composition of the central lymph. , 1989, Physiologia Bohemoslovaca.

[8]  J. Kvetina,et al.  Influence of the composition of rat central lymph on the pharmacokinetics (the steady state during infusion, bioavailability, absorption) of diazepam, studied in the blood and lymph. , 1990, Physiologia Bohemoslovaca.

[9]  R. Sawchuk,et al.  Effect of co‐administration of intralipidTM on the pharmacokinetics of cyclosporine in the rabbit , 1991, Biopharmaceutics & drug disposition.

[10]  V. Stella,et al.  Factors affecting the lymphatic transport of penclomedine (NSC-338720), a lipophilic cytotoxic drug: Comparison to DDT and hexachlorobenzene , 1992 .

[11]  N el Tayar,et al.  Solvent-dependent conformation and hydrogen-bonding capacity of cyclosporin A: evidence from partition coefficients and molecular dynamics simulations. , 1993, Journal of medicinal chemistry.

[12]  J. Barré,et al.  Effects of Plasma Lipid Levels on Blood Distribution and Pharmacokinetics of Cyclosporin A , 1993, Therapeutic drug monitoring.

[13]  K. Yamamoto,et al.  Effects of dietary fat levels on the absorption and tissue accumulation of probucol in the rat. , 1994, Arzneimittel-Forschung.

[14]  E. Anggard,et al.  Measurement of plasma probucol levels by high-performance liquid chromatography. , 1994, Journal of chromatography. B, Biomedical applications.

[15]  A. Hamsten,et al.  Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. , 1994, Journal of lipid research.

[16]  D. Hauss,et al.  Targeted lymphatic transport and modified systemic distribution of CI-976, a lipophilic lipid-regulator drug, via a formulation approach , 1994 .

[17]  G. Lopez-Berestein,et al.  Modification of Amphotericin B's Therapeutic Index by Increasing Its Association with Serum High‐Density Lipoproteins a , 1994, Annals of the New York Academy of Sciences.

[18]  D. B. Gomis,et al.  Simultaneous determination of vitamins D3, E and K1 and retinyl palmitate in cattle plasma by liquid chromatography with a narrow-bore column. , 1994, Journal of chromatography. B, Biomedical applications.

[19]  C. Porter,et al.  A simplified liquid chromatography assay for the quantitation of halofantrine and desbutylhalofantrine in plasma and identification of a degradation product of desbutylhalofantrine formed under alkaline conditions. , 1995, Journal of pharmaceutical and biomedical analysis.

[20]  M. Ueno,et al.  Mechanism of promotion of lymphatic drug absorption by milk fat globule membrane , 1995 .

[21]  C. Porter,et al.  Lymphatic transport of halofantrine in the triple-cannulated anesthetized rat model: effect of lipid vehicle dispersion. , 1996, Journal of pharmaceutical sciences.

[22]  C. Porter,et al.  Lipophilic prodrugs designed for intestinal lymphatic transport , 1996 .

[23]  A. Hamsten,et al.  Apolipoprotein B-48. , 1996, Methods in enzymology.

[24]  A. P. Arzamastsev,et al.  [Determination of bifonazole using HPLC in pharmacokinetic studies]. , 1996, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic].

[25]  S. Davis,et al.  Intestinal lymphatic transport of three retinoids in the rat after oral administration: Effect of lipophilicity and lipid vehicle , 1996 .

[26]  R. Krauss,et al.  Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness. , 1997, Circulation.

[27]  G. Edwards,et al.  Association of halofantrine with postprandially derived plasma lipoproteins decreases its clearance relative to administration in the fasted state. , 1998, Journal of pharmaceutical sciences.

[28]  L. Notarianni,et al.  Rapid and simple chromatographic method for the determination of diazepam and its major metabolites in human plasma and urine. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[29]  S. Noh,et al.  Marginal Zinc Deficiency Lowers the Lymphatic Absorption of α-Tocopherol in Rats , 1998 .

[30]  K. Wasan,et al.  Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs. , 1998, Journal of pharmaceutical sciences.

[31]  C. Porter,et al.  Differences in the lipoprotein binding profile of halofantrine in fed and fasted human or beagle plasma are dictated by the respective masses of core apolar lipoprotein lipid. , 1999, Journal of pharmaceutical sciences.

[32]  J. Fialip,et al.  High-performance liquid chromatographic determination of paclitaxel in rat serum: application to a toxicokinetic study. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[33]  M. Hussain,et al.  Assembly and Secretion of Chylomicrons by Differentiated Caco-2 Cells , 1999, The Journal of Biological Chemistry.

[34]  C. Porter,et al.  Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats. , 2000, Journal of pharmaceutical sciences.

[35]  M. Hussain.  A proposed model for the assembly of chylomicrons. , 2000, Atherosclerosis.

[36]  P. Tso,et al.  An examination of the factors affecting intestinal lymphatic transport of dietary lipids. , 2001, Advanced drug delivery reviews.

[37]  G. Edwards,et al.  Animal models for the study of intestinal lymphatic drug transport. , 2001, Advanced drug delivery reviews.

[38]  G. Gaedicke,et al.  Synthesis and preclinical characterization of a paclitaxel prodrug with improved antitumor activity and water solubility. , 2001, Bioconjugate chemistry.

[39]  C. Porter,et al.  Intestinal lymphatic drug transport: an update. , 2001, Advanced drug delivery reviews.

[40]  C. O’Driscoll.  Lipid-based formulations for intestinal lymphatic delivery. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[41]  K. Wasan.  The Role of Lymphatic Transport in Enhancing Oral Protein and Peptide Drug Delivery , 2002, Drug development and industrial pharmacy.

[42]  M. Khan,et al.  Development of a HPLC method for the determination of cyclosporin-A in rat blood and plasma using naproxen as an internal standard. , 2003, Journal of pharmaceutical and biomedical analysis.

[43]  H. Yamada,et al.  A Quantitative Concept of the Mechanism of Intestinal Lymphatic Transfer of Lipophilic Molecules , 1994, Pharmaceutical Research.

[44]  Ben J. Boyd,et al.  Drug Solubilization Behavior During in Vitro Digestion of Simple Triglyceride Lipid Solution Formulations , 2004, Pharmaceutical Research.

[45]  E. Donnachie,et al.  Differences in Lipoprotein Lipid Concentration and Composition Modify the Plasma Distribution of Cyclosporine , 1997, Pharmaceutical Research.

[46]  René Holm,et al.  Successful in silico predicting of intestinal lymphatic transfer. , 2004, International journal of pharmaceutics.

[47]  C. Porter,et al.  Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model , 2004, The Journal of pharmacy and pharmacology.

[48]  A. Hoffman,et al.  Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.